Time |
Platinum 3 & 4 |
Platinum 1 |
Platinum 2 |
Breakout room |
08.45 - 09.00 |
Conference Opening
Julie Storr, IPS President |
|
|
|
09.00 - 09.35 |
Session 1
Gaining organisational buy-in to infection prevention
Professor Dale Fisher, Senior Consultant and Head of Infectious Diseases, National University Hospital, Singapore
The objectives are to:
-
explain why successful infection prevention and control requires "buy-in" at all levels of an organisation
-
discuss why executive support is crucial, but can be challenging to obtain in financially challenged organisations
-
this talks describes sustainable “buy in” through a mix of methods…… draconian, innovative, inclusive, empowering and fun
|
|
|
|
09.35 - 10.10 |
Session 2
Using front line ownership to improve patient safety
Dr Michael Gardam, Director Infection Prevention and Control, University Health Network, Canada
The objectives are to:
-
introduce complexity science and explain how it can be used to improve patient safety
-
introduce the front line ownership, positive deviance, and liberating structures approaches
-
share our experience using these approaches in North America
|
|
|
|
10.10 - 10.45 |
Session 3
Hand hygiene - the ultimate microbiology-behaviour challenge
Hugo Sax, Head of Infection Control Program, University Hospital of Zurich, Switzerland
The objectives are to:
-
reflect on microbiological risks in the healthcare setting
-
reflect on risk perception and its impact on mental models
-
understand what this means for the case of hand hygiene
Supported by an educational grant from GOJO |
10.45 - 11.30 |
REFRESHMENTS AND EXHIBITION OPENING |
11.30-12.05 |
Session 4
EM Cottrell Lecture - The life and times of the urinary catheter
Martin Kiernan, Nurse Consultant Infection Prevention, Southport and Ormskirk Hospital NHS Trust
This is an IPS Teleclass |
|
|
|
12.10 - 12.20 |
IPS Annual General Meeting
This session is open to IPS members only |
Why Join IPS?
This session is for anyone interested in joining IPS. This is your opportunity to ask questions about the association. |
Exhibition Viewing |
12.20 – 13.45 |
LUNCH AND EXHIBITION VIEWING |
13.45 - 14.20 |
Session 5
Implementing national guidelines at a local level
Dr Fidelma Fitzpatrick, Consultant Microbiologist NationalI Clinical Lead, Beaumont Hospoital, HSE Patient Safety and Quality and Health Protection Surveillance Centre
The objectives are to:
-
identify what the challenges are when implementing national guidance
-
explain how we can tackle these challenges
-
outline how we can measure success
|
Session 9
Vomiting Larry – norovirus control
Catherine Makison Booth, Microbiologist, Health and Safety Laboratory, Harpur Hill
The objectives are to:
|
Session 12
Oral paper presentation
x 2
Visit the ‘Abstract’ page for further information on submitting an abstract. Closing date 24th June. |
New to Infection Prevention and Control workshop
For full programme information
CLICK HERE
|
14.25 – 15.00 |
Session 6
ECDC SITE Project
Dr Walter Zingg, Infection Control Program, University of Geneva Hospitals, Switzerland
The objectives are to:
-
explore effective infection prevention strategies
-
understand hospital organisation, management and structure to improve quality of care
-
explain structure and process indicators to measure success
|
Session 10
WINCL
Dr Evonne Curran, Nurse Consultant Infection Control, Health Protection Scotland
The objectives are to:
-
understand the evidence gaps around norovirus
-
describe the process of producing a research project to fill the gaps that IPCNs could participate in
-
describe how the project will be taken forward
-
detail what people have to do if they wish to be recruited
|
Session 13
Oral paper presentation
x 2
Visit the ‘Abstract’ page for further information on submitting an abstract. Closing date 24th June. |
15.00 - 15.35 |
Session 7
Guided poster walks and poster viewing in designated poster viewing area
Visit the ‘Abstract’ page for further information on submitting an abstract. Closing date 24th June. |
15.35 - 16.20 |
REFRESHMENTS AND EXHIBITION VIEWING |
16.20 – 17.30
|
Session 8
PATIENT EXPERIENCE
16.20 – 16.50
Patients' experience of MRSA screening: a South London perspective
Dr Carol Pellowe
Senior Lecturer Infection Control, King's College, London
The objectives are to:
-
analyse the similarities and differences in patients' experiences of screening
-
identify where there are deficits in the service
-
consider the means of improving the screening service
16.55 – 17.20
Patient experience – The elephant in the room
Claire Kilpatrick, Advisor Consultant on Infection Prevention and patient Safety,
17.20 -17.30
Question Panel |
Session 11
MULTI DRUG RESISTANT
GRAM-NEGATIVES
16.20 – 16.45
Controlling MDR-Gram-negatives
Professor Peter Wilson, Professor of Microbiology and consultant Microbiologist,
University College London Hospitals
The objectives are to:
-
describe the emerging threat of multidrug-resistant Gram negatives
-
outline evidence-based control strategies (with limited evidence)!
-
highlight areas requiring urgent research to develop optimal strategies
16.45 – 17.05
Multi drug resistant Gram-negatives in practice
Craig Bradley, Infection prevention and Control Specialist Nurse, University Hospital Birmigham NHS Foundation Trust
The objectives are to:
- explain the practical aspects of the control of MDR GN within an acute healthcare setting
- provide examples of practices that could and have been implemented
17.05 – 17.25
Gram negative and emerging resistance
Alice Nutbourne, Medical Student, King's College London
The objectives are to:
17.25 – 17.35
Question Panel |
Competences Workshop
For further information
CLICK HERE |
Mental Health Stream
For full programme information
CLICK HERE |
